News from us and our partners

Tags

Topics

0 results

News
5 December, 2023
The Franche-Comté Polyclinic & Moon Surgical showcase the Maestro System's simplicity and ease-of-use
News
5 December, 2023
CorWave announces the appointment of Fairuz Hasni as Vice President Human Resources
News
5 December, 2023
Sofinnova Partners launches Sofinnova.AI investment platform
News
5 December, 2023
Mission Therapeutics wins MHRA CTA for MTX325 in Parkinson's
News
4 December, 2023
Inventiva announces the positive recommendation of the third DMC of the Phase III clinical trial with lanifibranor in patients with NASH
News
30 November, 2023
Calliditas initiates clinical study to evaluate setanaxib in Alport Syndrome
News
29 November, 2023
deepc partners with Hyland to bring AI to medical imaging suite
News
21 November, 2023
Myricx Bio licenses antibody from WuXi Biologics for NMTi ADC
News
20 November, 2023
Elicit Plant makes C&EN’s list of '10 Start-Ups to Watch'
News
16 November, 2023
Elicit Plant wins EU registration for drought stress products
News
15 November, 2023
T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment
News
15 November, 2023
Inari Medical closes $250M acquisition of LimFlow
News
15 November, 2023
Myricx Bio appoints Dr Chris Martin as board chairman
News
13 November, 2023
Sofinnova Partners enhances leadership in Medtech acceleration with key appointments
News
8 November, 2023
AAVantgarde appoints Dr. Peter K. Kaiser to the Board of Directors
News
7 November, 2023
Recor Medical and Otsuka Medical Devices announce first FDA-approved Renal Denervation System for the treatment of hypertension

The Franche-Comté Polyclinic & Moon Surgical showcase the Maestro System's simplicity and ease-of-use

CorWave announces the appointment of Fairuz Hasni as Vice President Human Resources

Sofinnova Partners launches Sofinnova.AI investment platform

Mission Therapeutics wins MHRA CTA for MTX325 in Parkinson's

Inventiva announces the positive recommendation of the third DMC of the Phase III clinical trial with lanifibranor in patients with NASH

Calliditas initiates clinical study to evaluate setanaxib in Alport Syndrome

deepc partners with Hyland to bring AI to medical imaging suite

Myricx Bio licenses antibody from WuXi Biologics for NMTi ADC

Elicit Plant makes C&EN’s list of '10 Start-Ups to Watch'

Elicit Plant wins EU registration for drought stress products

T-Therapeutics raises £48 million Series A for development of next generation TCR therapeutics to transform cancer treatment

Inari Medical closes $250M acquisition of LimFlow

Myricx Bio appoints Dr Chris Martin as board chairman

Sofinnova Partners enhances leadership in Medtech acceleration with key appointments

AAVantgarde appoints Dr. Peter K. Kaiser to the Board of Directors

Recor Medical and Otsuka Medical Devices announce first FDA-approved Renal Denervation System for the treatment of hypertension